Viatris Acquires Oyster Point Pharma and Famy Life Sciences
Viatris Inc. announced on November 7 that it acquired two pharmaceutical companies: Oyster Point Pharma and Famy Life Sciences. The two acquisitions have an aggregate purchase price of approximately $700 million to $750 million. Viatris Inc. is a global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. In 2020, it reported $11.95 billion in revenue. Founded in 2015, Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases. In 2021, it reported $1.15 million in revenue. Famy Life Sciences is a drug development... Read More »
Sean “Diddy” Combs Acquires Medical Marijuana Assets from Cresco Labs and Columbia Care for $185 Million
Cresco Labs (CSE: CL) and Columbia Care (CSE: CCHW) announced on November 4 that they were divesting certain assets in New York, Massachusetts and Illinois. The undisclosed purchasing entity is owned by rapper Sean Combs and is acquiring the assets for a total of $185 million. This marks the 17th medical marijuana transaction of the year, according to the LevinPro HC database. Cresco Labs is one of the largest vertically integrated multi-state cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and... Read More »
Flora Growth Acquires Franchise Global Health in $29 Million Medical Marijuana Deal
Flora Growth acquired Franchise Global Health in a medical marijuana deal in which FGH is valued at approximately C$40 million (approximately $29.2 million USD). Flora Growth is an all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house brands and life sciences divisions. Franchise Global Health Inc., through its subsidiaries, is a multinational operator in the medical cannabis and pharmaceutical industries, with principal operations in Germany and with operations, assets, strategic partnerships and investments internationally. ... Read More »
MedMen Sells Florida Assets to Green Sentry Holdings for $83 Million
MedMen Enterprises Inc. sold its Florida assets to Florida-based Green Sentry Holdings LLC for $83 million in cash. The deal includes the sale of substantially all of MedMen’s Florida-based assets, including its license, dispensaries, inventory and cultivation operations. Additionally, MedMen agreed to license its trademarks in the state for two years, subject to termination rights, for a quarterly revenue-based fee. This acquisition follows MedMen’s previous divestment of its New York operations to Ascend Wellness Holdings in February 2022. Green Sentry Holdings LLC is associated with Brady Cobb, who is an attorney, lobbyist, strategist and consultant based in South Florida who... Read More »
AzurRz BioPharma Acquires First Wave Bio
AzurRz BioPharma, Inc., a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced that it has entered into a definitive agreement to acquire First Wave Bio, Inc. in a stock and cash transaction valued at $229 million. H.C. Wainwright & Co. acted as advisor to AzurRx in connection with the acquisition. Founded in 2015, First Wave Bio, Inc. is a clinical-stage biotechnology company specializing in the development of novel, gut-targeted, small molecule therapies for the treatment of auto-immune inflammatory bowel diseases (IBD) and other serious conditions. AzurRx also announced that it... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
